Interpreting Steris (STE) International Revenue Trends — Neutral

STE   Zacks Investment Research — November 10, 2025

Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

image for news Interpreting Steris (STE) International Revenue Trends

Global Ship Lease (GSL) Surpasses Q3 Earnings and Revenue Estimates — Positive

GSL   Zacks Investment Research — November 10, 2025

Global Ship Lease (GSL) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.27 per share. This compares to earnings of $2.45 per share a year ago.

image for news Global Ship Lease (GSL) Surpasses Q3 Earnings and Revenue Estimates

Somnigroup International Inc. (SGI) Hit a 52 Week High, Can the Run Continue? — Positive

SGI   Zacks Investment Research — November 10, 2025

Somnigroup International (SGI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

image for news Somnigroup International Inc. (SGI) Hit a 52 Week High, Can the Run Continue?

Investing in American Axle (AXL)? Don't Miss Assessing Its International Revenue Trends — Neutral

AXL   Zacks Investment Research — November 10, 2025

Explore American Axle's (AXL) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

image for news Investing in American Axle (AXL)? Don't Miss Assessing Its International Revenue Trends

Unveiling Beazer (BZH) Q4 Outlook: Wall Street Estimates for Key Metrics — Positive

BZH   Zacks Investment Research — November 10, 2025

Besides Wall Street's top-and-bottom-line estimates for Beazer (BZH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

image for news Unveiling Beazer (BZH) Q4 Outlook: Wall Street Estimates for Key Metrics

4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates — Negative

FDMT   Zacks Investment Research — November 10, 2025

4D Molecular Therapeutics, Inc. (FDMT) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimate of a loss of $1.02. This compares to a loss of $0.79 per share a year ago.

image for news 4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates

Lincoln Educational Services Corporation (LINC) Surpasses Q3 Earnings and Revenue Estimates — Positive

LINC   Zacks Investment Research — November 10, 2025

Lincoln Educational Services Corporation (LINC) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago.

image for news Lincoln Educational Services Corporation (LINC) Surpasses Q3 Earnings and Revenue Estimates

Why DNOW (DNOW) International Revenue Trends Deserve Your Attention — Neutral

DNOW   Zacks Investment Research — November 10, 2025

Explore DNOW's (DNOW) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

image for news Why DNOW (DNOW) International Revenue Trends Deserve Your Attention

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Sally Beauty (SBH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

image for news Seeking Clues to Sally Beauty (SBH) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Topgolf Callaway Brands Corp. (MODG) Hits Fresh High: Is There Still Room to Run? — Positive

MODG   Zacks Investment Research — November 10, 2025

Topgolf Callaway (MODG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

image for news Topgolf Callaway Brands Corp. (MODG) Hits Fresh High: Is There Still Room to Run?

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates — Negative

VYGR   Zacks Investment Research — November 10, 2025

Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.16 per share a year ago.

image for news Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates

Don't Overlook Monster Beverage (MNST) International Revenue Trends While Assessing the Stock — Positive

MNST   Zacks Investment Research — November 10, 2025

Review Monster Beverage's (MNST) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

image for news Don't Overlook Monster Beverage (MNST) International Revenue Trends While Assessing the Stock

Disney (DIS) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates — Positive

DIS   Zacks Investment Research — November 10, 2025

Besides Wall Street's top-and-bottom-line estimates for Disney (DIS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

image for news Disney (DIS) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

Southern First Bancshares, Inc. (SFST) Hit a 52 Week High, Can the Run Continue? — Positive

SFST   Zacks Investment Research — November 10, 2025

Southern First (SFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

image for news Southern First Bancshares, Inc. (SFST) Hit a 52 Week High, Can the Run Continue?

Don't Overlook Watsco (WSO) International Revenue Trends While Assessing the Stock — Positive

WSO   Zacks Investment Research — November 10, 2025

Evaluate Watsco's (WSO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

image for news Don't Overlook Watsco (WSO) International Revenue Trends While Assessing the Stock

Ahead of Spectrum (SPB) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics — Positive

SPB   Zacks Investment Research — November 10, 2025

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Spectrum (SPB), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

image for news Ahead of Spectrum (SPB) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Unlocking Dentsply (XRAY) International Revenues: Trends, Surprises, and Prospects — Neutral

XRAY   Zacks Investment Research — November 10, 2025

Explore how Dentsply's (XRAY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

image for news Unlocking Dentsply (XRAY) International Revenues: Trends, Surprises, and Prospects

What Analyst Projections for Key Metrics Reveal About Edgewell Personal (EPC) Q4 Earnings — Positive

EPC   Zacks Investment Research — November 10, 2025

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Edgewell Personal (EPC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

image for news What Analyst Projections for Key Metrics Reveal About Edgewell Personal (EPC) Q4 Earnings

Heritage Insurance Holdings, Inc. (HRTG) Hit a 52 Week High, Can the Run Continue? — Positive

HRTG   Zacks Investment Research — November 10, 2025

Heritage Insurance (HRTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

image for news Heritage Insurance Holdings, Inc. (HRTG) Hit a 52 Week High, Can the Run Continue?

Why CSG Systems (CSGS) International Revenue Trends Deserve Your Attention — Positive

CSGS   Zacks Investment Research — November 10, 2025

Evaluate CSG Systems' (CSGS) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

image for news Why CSG Systems (CSGS) International Revenue Trends Deserve Your Attention